Portfolio comparison
Curevac SE vs Tehram
Side-by-side portfolio analysis — patents indexed, year ranges, and activity timeline.
Company A
Curevac SE
Patents indexed
2
Year range
2024
Most recent
2024
biotechpharmaceuticaloncologygene_editingimmunotherapy
Top Patents2 enriched
US 12048738· 2024
Using mRNA to Teach the Body to Fight Prostate Cancer
US 12083190· 2024
How an mRNA Vaccine Teaches Your Body to Fight Rabies
Activity by Decade
2020s2
Company B
Tehram
Patents indexed
1
Year range
2016
Most recent
2016
pharmaceuticalbiotechmaterialshealthcare
Top Patents1 enriched
US 9370488· 2016
Making Insulin Last Longer with Tiny Coated Drug Particles
Activity by Decade
2010s1
How to use
Bookmark a comparison URL to save it. Format: /compare/companies?a=[slug]&b=[slug]. Also see patent-level comparison.